Prevalence, awareness, treatment, and control of hypertension in China data from the China National Nutrition and Health Survey 2002

Circulation

Volumn 118, Issue 25, 2008, Pages 2679-2686

  Wu, Yangfeng ^a   Huxley, Rachel ^b   Li, Liming ^a   Anna, Vibeke ^b   Xie, Gaoqiang ^c   Yao, Chonghua ^d   Woodward, Mark ^b,e   Li, Xian ^c   Chalmers, John ^b   Gao, Runlin ^c   Kong, Lingzhi ^f   Yang, Xiaoguang ^g  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b UNIVERSITY OF SYDNEY   (Australia)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f BEIJING HOSPITAL   (China)

^g CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Awareness; China; Hypertension; Prevalence; Prevention and control; Therapeutics

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHINA; CHINESE; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; URBAN RURAL DIFFERENCE;

ADOLESCENT; ADULT; ANTIHYPERTENSIVE AGENTS; AWARENESS; CHINA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 58249128376     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.788166     Document Type: Article

References (40)

1. World Health Organization. World Health Statistics 2006. Geneva, Switzerland: World Health Organization; 2006.
2. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases, part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746-2753.
3. Tunstall-Pedoe H, Connaghan J, Woodward M, Tolonen H, Kuulasmaa K. Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid-1990s, and the role of medication. BMJ. 2006;332:629-635.
4. World Health Organization. Preventing Chronic Diseases: A Vital Investment: A WHO Report. Geneva, Switzerland: World Health Organization; 2005.
5. China Ministry of Health. 2006 Annual Report on Health Statistics. Beijing, China: Peking Union Medical College Publishing House; 2006.
6. Zhou B, Wu Y, Yang J, Li Y, Zhang H, Zhao L. Overweight is an independent risk factor for cardiovascular disease in Chinese populations. Obes Rev. 2002;3:147-156.
7. Critchley J, Liu J, Zhao D, Wei W, Capewell S. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation. 2004;110:1236-1244.
8. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349:1269-1276.
9. Ezzati M, Vander Hoorn S, Lawes CMM, Leach R, James WPT, Lopez AD, Rodgers A, Murray CJL. Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med. 2005;2:404-412.
10. Vorster HH. The emergence of cardiovascular disease during urbanisation of Africans. Pub Health Nutr. 2002;5:239-243.
11. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97:596-601.
12. Huang JS. The summary report of the National Symposium on Heart and Vascular Diseases. The Collection of Scientific Reports on the National Symposium on Heart and Vascular Diseases. Beijing, China: People's Publishing House; 1960.
13. Wang LD, ed. Nutrition and Health Status in Chinese People. Beijing, China: People's Publishing House; 2005.
14. Committee for Revision of Chinese Guidelines for Prevention and Treatment of Patients with Hypertension. Chinese guidelines for prevention and treatment of patients with hypertension [in Chinese]. Chin J Hypertens. 2005;134:2-41.
15. Tao S, Wu X, Duan X, Fang W, Hao J, Fan D, Wang W, Li Y. Hypertension prevalence and status of awareness, treatment and control in China. Chin Med J. 1995;108:483-489.
16. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, Huang G, Reynolds RF, Su S, Whelton PK, He J, for the Inter Asia Collaborative Group. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension. 2002;40:920-927.
17. Rao K, Chen Y, Chen X, Mao J. Selection of a national sample for acquisition of national health information in China. Chin Health Stat. 1992;9:1-6.
18. World Health Organization, International Society of Hypertension. 1999 World Health Organization-International Society of hypertension guidelines for the management of hypertension: Guidelines Subcommittee. J Hypertens. 1999;17:151-183.
19. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
20. Deepa R, Shanthirani CS, Pradeepa R, Mohan V. Is the "rule of halves" in hypertension still valid? Evidence from the Chennai Urban Population Study. J Assoc Physicians India. 2003;51:153-157.
21. Weinehall L, Ohgren B, Persson M, Stegmayr B, Boman K, Hallmans G, Lindholm LH. High remaining risk in poorly treated hypertension: the "rule of halves" still exists. J Hypertens. 2002;20:2081-2088.
22. Joshi SR, Shah SN. Control of blood pressure in India: rule of halves still very much valid. J Assoc Physicians India. 2003;51:151-152.
23. Ong KL, Cheung BMY, Man YB, Lau CP, Lam KSL. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69-75.
24. Kaplan NM, Opie LH. Controversies in hypertension. Lancet. 2006;367:168-176.
25. Reynolds K, Gu D, Muntner P, Wu X, Chen J, Huang G, Duan X, Whelton PK, He J, for the InterASIA Collaborative Group. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens. 2003;21:1273-1281.
26. Muntner P, Gu D, Wu X, Duan X, Wenqi G, Whelton PK, He J, for the InterASIA Collaborative Group. Factors associated with hypertension awareness, treatment, and control in a representative sample of the Chinese population. Hypertension. 2004;43:578-585.
27. Agyemang C. Rural and urban differences in blood pressure and hypertension in Ghana, West Africa. Public Health. 2006;120:525-533.
28. Nissinen A, Kastarinen M, Tuomilehto J. Community control of hypertension: experiences from Finland. J Hum Hypertens. 2004;18:553-556.
29. Scheltens T, Bots ML, Numans ME, Grobbee DE, Hoes AW. Awareness, treatment and control of hypertension: the "rule of halves" in an era of risk-based treatment of hypertension. J Hum Hypertens. 2007;21:99-106.
30. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223.
31. Wang TJ, Ausiello JC, Stafford RS. Trends in antihypertensive drug advertising, 1985-1996. Circulation. 1999;99:2055-2057.
32. Wu Y, Ma G, Hu Y, Li YP, Li X, Cui Z-H, Chen CM, Kong LZ. The current status in prevalence of overweight and obesity in China: data from the China National Nutrition and Health Survey (NNAHS) [in Chinese]. Zhonghua Yi Zue Za Zhi. 2005;39:316-320.
33. Rodgers A, Lawes C, Gaziano TTV. The growing burden of risk from high blood pressure, cholesterol, and bodyweight. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, eds. Disease Control Priorities in Developing Countries. Washington DC: International Bank for Reconstruction and Development/The World Bank; 2006.
34. Bell AC, Adair LS, Popkin BM. Understanding the role of mediating risk factors and proxy effects in the association between socio-economic status and untreated hypertension. Soc Sci Med. 2004;9:275-283.
35. Huang Z, Wu X, Stamler J, Rao X, Stamler R, He H, Zhou B, Taylor J, Li Y, Xiao Z, Williams D, Cen R, Zhang H. A north-south comparison of blood pressure and factors related to blood pressure in the People's Republic of China: a report form the PRC-USA Collaborative Study of Cardiovascular Epidemiology. J Hypertens. 1994;12:1103-1112.
36. Stamler R, Liu L, Nichols R, Huang D, Long Z, Xie J, Elliott P. Blood pressure and life style in the People's Republic of China: three samples in the INTERSALT Study. J Hum Hypertens. 1993;7:429-435.
37. Lisheng L, Jinxiang X, Weiqing F. Urinary cations and blood pressure: a collaborative study of 16 districts in China. J Hypertens Suppl. 1988;6:S587-S590.
38. Zhao L, Stamler J, Yan LL, Zhou B, Wu Y, Liu K, Daviglus ML, Dennis BH, Elliott P, Ueshima H, Yang J, Zhu L, Guo D. for the INTERMAP Research Group. Blood pressure differences between northern and southern Chinese: role of dietary factors: the International Study on Macronutrients and Blood Pressure. Hypertension. 2004;43:1332-1337.
39. Dickinson HO, Mason JM. Nicolson DJ, Campbell F, Beyer FR, Cook JV, Williams B. Ford GA. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens. 2006;24:215-233.
40. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003;326:1427.